This document governs access to and use of the FINOVAX training and mentorship platform ("FINOVAX", "Company", "We", "Us", "Our"). FINOVAX operates as an independent professional training and education platform. These policies are drafted in accordance with Indian laws and international best practices.
By accessing, enrolling, or using FINOVAX services, you confirm that you have read, understood, and agreed to be legally bound by this document and all annexures herein.
1.1 FINOVAX provides training, education, mentorship, and skill-development services only.
1.2 FINOVAX is not:
1.3 FINOVAX does not fall under regulated activities of SEBI (India) or any equivalent international regulator.
1.4 No employment, partnership, agency, fiduciary, or joint venture relationship is created.
2.1 Users must be 18 years or older and legally competent.
2.2 Users are solely responsible for ensuring that participation is lawful in their jurisdiction.
2.3 FINOVAX may request KYC or verification documents to comply with AML/CFT and platform integrity requirements.
3.1 FINOVAX charges a one-time training fee of 1,000 USDT, unless otherwise stated in writing.
3.2 Fees are strictly for training access, mentorship, systems, digital content, and administrative services.
3.3 Fees do not represent capital, investment, or refundable deposits.
3.4 Users are responsible for all taxes, duties, and reporting obligations in their jurisdiction.
4.1 Eligible users may receive complimentary products equivalent to 2% of the training fee per month, for a maximum of 50 months, subject to compliance.
4.2 The products offered under this benefit may include products manufactured or marketed by DXN, a globally recognized wellness brand with presence in multiple countries and territories.
4.3 Important Clarification:
4.4 Any purchase, sourcing, or distribution of DXN products under this benefit is done independently by FINOVAX or its users at an individual level, as part of FINOVAX’s internal value-back and community-building strategy.
4.5 The inclusion of DXN products is intended solely to promote wellness awareness and community engagement and should not be construed as a joint business activity.
4.6 This benefit:
4.7 Product availability may vary by geography; equivalent substitutions may apply.
5.1 Any income or performance references (including "2× income potential") are illustrative only.
5.2 FINOVAX does not guarantee income, profits, or results.
5.3 Outcomes depend on individual effort, skills, consistency, leadership ability, and market conditions.
6.1 FINOVAX may offer a conditional refund of the training fee.
6.2 Refund eligibility requires:
6.3 Refund decisions are final and at FINOVAX’s sole discretion.
7.1 Users must not:
7.2 Violations may result in suspension or termination without refund.
All content, systems, materials, trademarks, and branding are the exclusive intellectual property of FINOVAX and protected under Indian and international laws.
FINOVAX shall not be liable for indirect, incidental, consequential, or economic losses. Participation is at the sole risk of the user.
10.1 Governing Law: India.
10.2 Disputes shall be resolved through arbitration under the Arbitration and Conciliation Act, 1996 (India).
10.3 International users consent to arbitration seated in India or another mutually agreed jurisdiction.